Insider Shareholders with Direct Ownership of Biocryst Pharmaceuticals Inc (BCRX)
This section provides a comprehensive overview of the insiders with direct ownership of Biocryst Pharmaceuticals Inc (BCRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOCRYST PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jon P Stonehouse
President & CEO |
1,154,906 | 850,157 | 1,101,019 $8.33 Million | 23 |
Dec 14, 2024
Reduced 2.44%
|
|
Charles K Gayer
Chief Commercial Officer |
223,000 | 22,673 | 300,057 $2.27 Million | 8 |
Dec 14, 2024
Reduced 2.68%
|
|
Yarlagadda S Babu
Chief Discovery Officer |
247,000 | 104,046 | 298,541 $2.26 Million | 8 |
Nov 14, 2022
Reduced 9.55%
|
|
Alane P Barnes
Chief Legal Officer |
344,114 | 149,547 | 294,490 $2.23 Million | 15 |
Dec 14, 2024
Reduced 2.84%
|
|
Helen M. Thackray
Chief R&D Officer |
306,000 | 41,011 | 264,989 $2.01 Million | 12 |
Dec 14, 2024
Reduced 2.63%
|
|
Anthony Doyle
Chief Financial Officer |
254,558 | 21,547 | 259,628 $1.97 Million | 9 |
Dec 14, 2024
Reduced 2.95%
|
|
Robert Alexander Ingram
Director |
30,593 | 0 | 100,198 $758,498 | 11 |
Feb 28, 2023
Added 2.2%
|
|
Nancy J Hutson
Director |
171,522 | 148,199 | 86,638 $655,849 | 13 |
Dec 13, 2024
Reduced 7.48%
|
|
Vincent Milano
Director |
66,084 | 0 | 76,084 $575,955 | 15 |
Nov 29, 2024
Added 0.98%
|
|
Steve Aselage
Director |
41,546 | 0 | 70,159 $531,103 | 10 |
Jun 12, 2024
Added 8.86%
|
|
Kenneth B Lee Jr
Director |
59,611 | 6,000 | 68,863 $521,292 | 5 |
Jun 13, 2023
Added 19.56%
|
|
Theresa Heggie
Director |
47,142 | 6,698 | 52,852 $400,089 | 19 |
Jun 14, 2024
Reduced 11.25%
|
|
Alan G Levin
Director |
51,771 | 0 | 51,771 $391,906 | 12 |
Jun 12, 2024
Added 11.64%
|
|
William P Sheridan
Chief Medical Officer |
388,125 | 365,962 | 37,954 $287,311 | 9 |
Mar 10, 2022
Reduced 3.56%
|
|
George B Abercrombie
Director |
139,098 | 112,667 | 36,431 $275,782 | 18 |
Jun 12, 2024
Added 15.77%
|
|
Steven K Galson
Director |
58,371 | 0 | 36,431 $275,782 | 4 |
Jun 12, 2024
Added 15.77%
|
|
Amy E Mc Kee
Director |
36,431 | 8,600 | 27,831 $210,680 | 4 |
Jun 24, 2024
Reduced 23.61%
|
|
Machelle Sanders
Director |
36,431 | 8,689 | 27,742 $210,006 | 5 |
Jun 17, 2024
Reduced 14.46%
|
|
Michael L Jones
Exec. Director, Finance - PAO |
27,150 | 11,345 | 16,653 $126,063 | 8 |
Dec 19, 2022
Added 26.16%
|